Ménard Sandie, Ben Haddou Tanila, Ramadani Arba Pramundita, Ariey Frédéric, Iriart Xavier, Beghain Johann, Bouchier Christiane, Witkowski Benoit, Berry Antoine, Mercereau-Puijalon Odile, Benoit-Vical Françoise
Emerg Infect Dis. 2015 Oct;21(10):1733-41. doi: 10.3201/eid2110.150682.
Plasmodium falciparum resistance to artemisinin derivatives in Southeast Asia threatens global malaria control strategies. Whether delayed parasite clearance, which exposes larger parasite numbers to artemisinins for longer times, selects higher-grade resistance remains unexplored. We investigated whether long-lasting artemisinin pressure selects a novel multidrug-tolerance profile. Although 50% inhibitory concentrations for 10 antimalarial drugs tested were unchanged, drug-tolerant parasites showed higher recrudescence rates for endoperoxides, quinolones, and an antifolate, including partner drugs of recommended combination therapies, but remained susceptible to atovaquone. Moreover, the age range of intraerythrocytic stages able to resist artemisinin was extended to older ring forms and trophozoites. Multidrug tolerance results from drug-induced quiescence, which enables parasites to survive exposure to unrelated antimalarial drugs that inhibit a variety of metabolic pathways. This novel resistance pattern should be urgently monitored in the field because this pattern is not detected by current assays and represents a major threat to antimalarial drug policy.
东南亚地区恶性疟原虫对青蒿素衍生物的耐药性威胁着全球疟疾控制策略。延迟的寄生虫清除,使得更多数量的寄生虫在更长时间内暴露于青蒿素之下,是否会导致更高等级的耐药性仍有待探索。我们研究了长期的青蒿素压力是否会选择出一种新的多药耐受性模式。尽管所测试的10种抗疟药物的50%抑制浓度没有变化,但耐药物的寄生虫对过氧化物、喹诺酮类药物和一种抗叶酸药物(包括推荐联合疗法中的伙伴药物)表现出更高的复发率,但对阿托伐醌仍敏感。此外,能够抵抗青蒿素的红细胞内期的年龄范围扩展到了更老的环状体和滋养体。多药耐受性源于药物诱导的静止状态,这使得寄生虫能够在接触抑制多种代谢途径的不相关抗疟药物后存活下来。这种新的耐药模式应在实地紧急监测,因为目前的检测方法无法检测到这种模式,并且它对抗疟药物政策构成了重大威胁。